{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-21-033451","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2021-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.124061+00:00","generated_at":"2026-06-28T23:15:43.324580+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nu Skin estimates Q3 revenue $637-642M, below expectations due to delta variant disruptions","bullets":["Estimated Q3 2021 revenue between $637M and $642M, softer than anticipated.","Delta variant caused unexpected disruptions, especially in Mainland China and Southeast Asia, impacting sales and promotions.","U.S. Collagen+ launch drove strong growth; Tencent digital tools introduced in China during the quarter.","Full Q3 results and revised 2021 guidance to be announced on November 3, 2021.","Annual 2021 revenue expected to be up modestly year over year, management remains confident in strategy."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-21-033451","json":"https://secwatch.observer/filing/0001140361-21-033451.json","markdown":"https://secwatch.observer/filing/0001140361-21-033451.md","text":"https://secwatch.observer/filing/0001140361-21-033451.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036121033451/0001140361-21-033451-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036121033451/brhc10029555_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T23:15:43.324580+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}